Stay updated with breaking news from Reverse Transcriptase Inhibitors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BANGALORE, India, April 29, 2022 /PRNewswire/ -- The Global Antiviral Drugs Market is Segmented by Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System
/PRNewswire/ -- The Global Antiviral Drugs Market is Segmented by Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System...
/PRNewswire/ -- The Global Antiviral Drugs Market is Segmented by Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System...
Market OverviewOver 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF. Evidence assures positive outcomes through early initiation of ART drugs for pediatric HIV infection treatment. Focus of regulatory autho...
Share: Newark, NJ, May 24, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global antiviral drugs market is expected to grow from USD 44.01 Billion in 2020 and to reach USD 51.67 Billion by 2028, growing at a CAGR of 2.0% during the forecast period 2021-2028. The factors driving the market are growing surge in healthcare framework payout ability, the extent of a well-established supply chain, increasing interest to brace the evolution of novel antiviral drugs, advances in the formulation such as fixed-dose combination and soaring requirement of diseases specific ...